Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 4

Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study

Pages
1960–1968
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Judicious use of medical devices is of pivotal importance.Key words: Solid-organ transplant recipients, drug-resistant, bacteremia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of this study is to evaluate the distribution, sources, clinical features, and mortality rates of bacteremia due to evaluation of extensively drug-resistant (XDR) gram negative among solid-organ transplant (SOT) recipients.
📊
Key Findings & Data:Materials and methods: A retrospective study of SOT recipients with bacteremia due to XDR gram-negative pathogens in 11 centers between 2016 and 2018 was conducted.
💡
Conclusion & Impact:Judicious use of medical devices is of pivotal importance.Key words: Solid-organ transplant recipients, drug-resistant, bacteremia
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: The aim of this study is to evaluate the distribution, sources, clinical features, and mortality rates of bacteremia due to evaluation of extensively drug-resistant (XDR) gram negative among solid-organ transplant (SOT) recipients. Materials and methods: A retrospective study of SOT recipients with bacteremia due to XDR gram-negative pathogens in 11 centers between 2016 and 2018 was conducted. Patients’ records were evaluated. Results: Of 171 bacteremia that occurred in 164 SOT recipients, 93 (56.7%) were liver, 46 (28%) kidney, 14 (8.5%) heart, and 11 (6.7%) lung recipients. Bacteremia episodes were recorded in the first year in 63.7% of the patients (n = 109), early-onset bacteremia was recorded in 45% (n = 77) of the episodes. In multivariate analysis, catheter-associated bacteremia was an independent risk factor for 7-day mortality (p = 0.037), and early-onset bacteremia was found as an independent risk factor for 30-day mortality (p = 0.017). Conclusion: Difficult-to-treat infections due to XDR bacteria in SOT recipients shadow the success of transplantation. Central venous catheters seem to be the main risk factor. Judicious use of medical devices is of pivotal importance.Key words: Solid-organ transplant recipients, drug-resistant, bacteremia

🔖

Cite This Article

EGELİ, T., ÇINAR, G., YALÇIN, T. Y., BAYINDIR, Y., ARI, A., AZAP, Ö., ÇABADAK, H., KUTSOYLU, O. Ö. E., SARICAOĞLU, E. M., TEKÇE, Y. T., KÖSE, A., KIZILATEŞ, F., ÖNDER, K. D., ALIŞKAN, H. E., KIZMAZ, Y. U., KURŞUN, E., HABERAL, M., ALBAY, Y. (2022). Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 4, 1960–1968. https://ajindex.com/articles/609611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Bartoletti M, Giannella M, Tedeschi S, Viale P. Multidrugresistant bacterial infections in solid organ transplant candidates and recipients. Infectious Disease Clinics of North America 2018
  2. 32 (3): 551-580. doi: 10.1016/j.idc.2018.04.004 2. Singh N, Limaye AP. Infections in solid-organ transplant recipients. In: Mandell GL, Bennett JE, Dolin R (editors). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Updated ed. Philadelphia, PA, USA: Churchill Livingstone
  3. pp. 3440-3452 3. Qiao B, Wu J, Wan Q, Zhang S, Ye Q. Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia. BMC infectious diseases 2017
  4. 17 (1): 171. doi: 10.1186/s12879-017-2276-1 4. Oriol I, Sabe N, Simonetti AF, Llado L, Manonelles A et al. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study. Transplant International 2017
  5. 30 (9): 903-913. doi: 10.1111/ tri.12984 5. Shendi AM, Wallis G, Painter H, Harber M, Collier S. Epidemiology and impact of bloodstream infections among kidney transplant recipients: A retrospective single-center experience. Transplant Infectious Disease 2018
  6. 20 (1). doi: 10.1111/tid.12815 6. Serefhanoğlu K, Timurkaynak F, Arslan H, Karakayalı H. Bacteremia among liver and kidney transplant recipients: etiologic agents and antimicrobial susceptibilities. Brazilian Journal of Infectious Diseases 2011
  7. 15 (4): 408-409. doi: 10.1016/S1413-8670 (11)70218-5 7. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. American Journal of Transplantation 2009
  8. 9 (4): 835-843. doi: 10.1111/j.1600- 6143.2009.02559.x 8. Candel FJ, Grima E, Matesanz M, Cervera C, Soto G et al. Bacteremia and septic shock after solid-organ transplantation. Transplantation Proceedings 2005
  9. 37 (9): 4097-4099. doi: 10.1016/j.transproceed.2005.09.181 9. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 2012
  10. 18 (3): 268-281. doi: 10.1111/j.1469-0691.2011.03570.x 10. Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R et al. Diagnostic and th